Sector ratings Eisai Co., Ltd.

Stocks

Market Closed - Japan Exchange Other stock markets 12:00:00 17/07/2026 pm IST			5-day change	1st Jan Change
4,450.00 ^JPY	+2.58%		+3.58%	-4.51%

15/07	Bioarctic AB Partner Eisai Presents Real-World Leader Study Results for Leqembi in Early Alzheimer?S Disease	CI
14/07	Eisai Co., Ltd. and Biogen Inc. Present Real-World LEADER Study Results For LEQEMBI At AAIC 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Fundamentals
EISAI CO., LTD.	773.54Cr	AA
ELI LILLY AND COMPANY	1,05100Cr	A
JOHNSON & JOHNSON	61TCr	BBB
ABBVIE INC.	45TCr	AA	-
ROCHE HOLDING AG	33TCr	AA
NOVARTIS AG	28TCr	AAA
ASTRAZENECA PLC	26TCr	A
NOVO NORDISK A/S	22TCr	A
AMGEN INC.	20TCr	A
GILEAD SCIENCES, INC.	17TCr	AA
PFIZER INC.	14TCr	A
BRISTOL-MYERS SQUIBB COMPANY	12TCr	A
VERTEX PHARMACEUTICALS INCORPORATED	12TCr	AA
SANOFI	11TCr	AA
GSK PLC	10TCr	AA
CHUGAI PHARMACEUTICAL CO., LTD.	7.42TCr	AA
BAYER AG	5.45TCr	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	5.33TCr	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	5.17TCr	AA
HALEON PLC	4.42TCr	AA
Average	22.3TCr	AA
Weighted average by Cap.		AA